Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke
暂无分享,去创建一个
A Gregory Sorensen | Walter J Koroshetz | Jonathan Rosand | Pamela W Schaefer | Ona Wu | K. Furie | A. Sorensen | W. Koroshetz | P. Schaefer | O. Wu | E. Arsava | A. Singhal | H. Ay | J. Rosand | Hakan Ay | E Murat Arsava | Karen L Furie | Aneesh B Singhal | R Gilberto Gonzalez | R. González | A. Sorensen | P. W. Schaefer | R. G. Gonzalez | E. M. Arsava
[1] T Walther,et al. Larger Anastomoses in Angiotensinogen-Knockout Mice Attenuate Early Metabolic Disturbances after Middle Cerebral Artery Occlusion , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] D. Heistad,et al. Impaired dilatation of cerebral arterioles in chronic hypertension. , 1990, Blood vessels.
[3] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.
[4] T Suenaga,et al. Alterations in glia and axons in the brains of Binswanger's disease patients. , 1997, Stroke.
[5] M. Fornage,et al. Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.
[6] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[7] Fisher Cm,et al. Binswanger's encephalopathy: a review , 1989 .
[8] Carl D Langefeld,et al. Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. , 2004, Radiology.
[9] C. Fisher. Binswanger's encephalopathy: a review , 2004, Journal of Neurology.
[10] K. Furie,et al. An evidence‐based causative classification system for acute ischemic stroke , 2005, Annals of neurology.
[11] F. Barkhof,et al. CT and MRI Rating of White Matter Lesions , 2002, Cerebrovascular Diseases.
[12] T. Iwamoto,et al. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. , 1995, Stroke.
[13] F. Fazekas,et al. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[14] P. Scheltens,et al. Age, Hypertension, and Lacunar Stroke Are the Major Determinants of the Severity of Age-Related White Matter Changes , 2006, Cerebrovascular Diseases.
[15] M. Moskowitz,et al. Enlarged Infarcts in Endothelial Nitric Oxide Synthase Knockout Mice are Attenuated by Nitro-L-Arginine , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] J. V. van Swieten,et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. , 1991, Brain : a journal of neurology.
[17] V. Hachinski,et al. Prognostic Importance of Leukoaraiosis in Patients With Symptomatic Internal Carotid Artery Stenosis , 2002, Stroke.
[18] M. O’Sullivan,et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis , 2002, Neurology.
[19] A. Roses,et al. Apolipoprotein E Isoform-Specific Differences in Outcome from Focal Ischemia in Transgenic Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] F. Fazekas,et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.
[21] T Suenaga,et al. Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. , 1996, Stroke.
[22] Eric E. Smith,et al. Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy , 2006, Neurology.
[23] B. Melegh,et al. Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis. , 2006, Current medicinal chemistry.
[24] Karen J. Ferguson,et al. Intracranial area: a validated method for estimating intracranial volume. , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[25] R. D'Agostino,et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. , 2006, Archives of neurology.
[26] Nancy J Fischbein,et al. Regional Angiographic Grading System for Collateral Flow: Correlation With Cerebral Infarction in Patients With Middle Cerebral Artery Occlusion , 2004, Stroke.
[27] Jeffrey L. Saver,et al. Cerebral White Matter Hyperintensities on MRI: Current Concepts and Therapeutic Implications , 2006, Cerebrovascular Diseases.
[28] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[29] W. Sterling Edwards,et al. Blood Vessels , 1959 .
[30] M. Laakso,et al. Apolipoprotein E Polymorphism and Acute Ischemic Stroke: A Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging Study , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] J. Miller,et al. Age-related sensitivity to kainate neurotoxicity , 1991, Experimental Neurology.
[32] T. Westfall,et al. ALTERATIONS IN THE , 1985 .
[33] Tadashi Nagayama,et al. Microvasculature of the human cerebral white matter: Arteries of the deep white matter , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.
[34] Eric E. Smith,et al. Validation of Intracranial Area as a Surrogate Measure of Intracranial Volume When Using Clinical MRI , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[35] A. Sorensen,et al. Conversion of Ischemic Brain Tissue Into Infarction Increases With Age , 2005, Stroke.
[36] G. Mies,et al. Ischemic injury in experimental stroke depends on angiotensin II , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] F. Buonanno,et al. Predicting Tissue Outcome in Acute Human Cerebral Ischemia Using Combined Diffusion- and Perfusion-Weighted MR Imaging , 2001, Stroke.
[38] J. Growdon,et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. , 2006, Neurology.
[39] F. Fazekas,et al. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants. , 1996, Stroke.
[40] D. Tanné,et al. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. , 1998, Circulation.
[41] K. Meguro,et al. Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging , 1990, Annals of neurology.
[42] Norman J Beauchamp,et al. White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke , 2004, Stroke.
[43] I. Akiguchi,et al. Coagulation activation in patients with Binswanger disease. , 1999, Archives of neurology.
[44] C. Beaulieu,et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome , 1999, Annals of neurology.